Biologists Release Endangered California Butterfly Larvae into Native Habitat
- Details
- Written by IVN
- Category: News
San Diego, California - A team of wildlife biologists from the San Diego Zoo, the U.S. Fish and Wildlife Service (USFWS), and the Conservation Biology Institute released more than 1,700 larvae of the endangered Quino checkerspot butterfly (Euphydryas editha quino) within its native range on the San Diego National Wildlife Refuge on Monday, Nov. 20, 2017. This is the second round of captive-rearing and release efforts for this California and Northern Baja California native butterfly species, whose population has been in drastic decline over the last decade.
Unique Partnership Brings Zoo Science and Community Experience Together to Save Elephant Babies
- Details
- Written by Imperial Valley News
- Category: News
San Diego, California - A team of animal health experts from San Diego Zoo Global recently spent time in Kenya working with the Reteti Elephant Sanctuary in the Namunyak community to enhance the medical care and animal husbandry capabilities of this facility. The elephant orphanage was recently founded in the area to care for young elephants brought to the conservancy for supportive care and rehabilitation.
FDA approves first two-drug regimen for certain patients with HIV
- Details
- Written by IVN
- Category: News
Washington, DC - The U.S. Food and Drug Administration today approved Juluca, the first complete treatment regimen containing only two drugs to treat certain adults with human immunodeficiency virus type 1 (HIV-1) instead of three or more drugs included in standard HIV treatment. Juluca is a fixed-dose tablet containing two previously approved drugs (dolutegravir and rilpivirine) to treat adults with HIV-1 infections whose virus is currently suppressed on a stable regimen for at least six months, with no history of treatment failure and no known substitutions associated with resistance to the individual components of Juluca.
Online Lingerie Marketer Prohibited from Deceiving Shoppers About Negative-Option Programs
- Details
- Written by IVN
- Category: News
Washington, DC - An online lingerie marketer has agreed to return more than $1.3 million to customers to settle Federal Trade Commission charges that it deceived shoppers who enrolled in a negative-option membership program offering discounts and other benefits, and made it hard for them to cancel their memberships.
Restoring Internet Freedom and Returning FTC Competition and Consumer Protections to Broadband Subscribers
- Details
- Written by IVN
- Category: News
Washington, DC - Today, Federal Communications Commission Chairman Ajit Pai circulated to FCC Commissioners a draft order in the Restoring Internet Freedom proceeding. Acting Federal Trade Commission Chairman Maureen K. Ohlhausen provided the following statement:
Steps to promote development of generic versions of opioids formulated to deter abuse
- Details
- Written by FDA Commissioner Scott Gottlieb, M.D.
- Category: News
Washington, DC - As we continue to confront the staggering human and economic toll created by opioid abuse and addiction, we’re focused on taking actions that reduce the scope of new addiction by decreasing unnecessary exposure to opioids. At the same time, we also must take steps to help those with acute and chronic pain who need access to medicines, including opioids, get access to improved alternatives. Until we’re able to find new non-opioid forms of pain management for those who need treatment for pain, it’s critical that we also continue to promote the development of opioids that are harder to manipulate and abuse, and take steps to encourage their use over opioids that don’t offer any form of abuse deterrence.
Page 1023 of 3785